Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S Cashflow Statement

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Zealand Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    C2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS    		—
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-847-1,018-1,202-704-1,079
    Depreciation
    Non-Cash Items22.1-22.8151177-106
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital93.3-211-9.5176229
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-689-1,212-942-426-931
    Capital Expenditures-25-22.1-11.7-23.7-13.1
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-1724.01293-1,070-7,320
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-197-18.1281-1,094-7,333
    Financing Cash Flow Items-42.7-46.9-47.4-71.9-237
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities7611,3335889078,288
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-121169-59.9-62031